Navigation Links
Cellular Dynamics International Announces Launch of Initial Public Offering

MADISON, Wis., July 10, 2013 /PRNewswire/ -- Cellular Dynamics International, Inc., a developer and manufacturer of fully functioning human cells in industrial quantities to precise specifications, today announced that it has commenced an initial public offering of 3,846,000 shares of common stock pursuant to a registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission ("SEC").  In addition, the underwriters will have a 30-day option to purchase up to an additional 576,900 shares of common stock from the Company. The initial public offering price is currently expected to be between $12.00 and $14.00 per share of common stock.

The Company intends to use the net proceeds that it receives in the offering for research and product development activities; sales and marketing activities, including expansion of its sales force to support the ongoing commercialization of its products; property, plant and equipment, including the build-out of its laboratory in California, and intellectual property; and for working capital and other general corporate purposes.

J.P. Morgan Securities LLC is acting as sole book-running manager for the offering, and Cowen and Company, LLC and Leerink Swann LLC are acting as co-managers.

A registration statement relating to these securities has been filed with the SEC but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The offering will be made only by means of a prospectus. Copies of the preliminary prospectus relating to the offering, and the final prospectus when available, may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone (866) 803-9204.

Forward-looking Statements

This press release includes "forward-looking statements," including with respect to the proposed initial public offering and the Company's intended use of proceeds. Forward-looking statements are subject to known and unknown risks and uncertainties, many of which may be beyond the Company's control. The forward-looking information presented in this press release is not a guarantee of future events, and that actual events may differ materially from those made in or suggested by the forward-looking information contained in this press release. In addition, forward-looking statements generally can be identified by the use of forward-looking terminology such as "may," "plan," "seek," "expect," "intend," "estimate," "anticipate," "believe" or "continue" or the negative thereof or variations thereon or similar terminology. Any forward-looking information presented herein is made only as of the date of this press release, and the Company does not undertake any obligation to update or revise any forward-looking information to reflect changes in assumptions, the occurrence of unanticipated events, or otherwise.

Joleen Rau  
Senior Director, Marketing & Communications
Cellular Dynamics International, Inc.
608 310-5142 

SOURCE Cellular Dynamics International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Cellular Biomedicine Group Announces Expansion in the Osteoarthritis and Rheumatoid Arthritis Market
2. Cellular Therapy and Cord Blood 2013 Market Report
3. Cellular Biomedicine Group Announces Appointment of Corporate Controller
4. Cellular Dynamics International Expands MyCell Products Line with Disease Models, Genetic Engineering Patents
5. Cellular Dynamics International Files Registration Statement for Proposed Initial Public Offering
6. Cellular Biomedicine Group Achieves 50% Enrollment Milestone in Phase I Clinical Trial for Knee Osteoarthritis
7. Intra-Cellular Therapies Appoints Professor Sir Michael Rawlins to its Board of Directors
8. Top Genetic and Cellular Researchers Honored at ASGCT 16th Annual Meeting
9. Exit discovered in cellular garbage truck
10. ASGCT Annual Meeting to Highlight Latest Advances in Genetic and Cellular Therapeutics
11. Cellular Biomedicine Group Provides Update and 2013 Milestones
Post Your Comments:
(Date:10/13/2015)... ... , ... The shortlist of finalists for the Pistoia Alliance President’s Startup Challenge ... from across Europe and the USA. , The Startup Challenge 2015 has seen startup ... in life sciences R&D, with over 30 entries submitted. A panel of expert judges ...
(Date:10/13/2015)... , ... October 13, 2015 , ... ... Universal SuperHeat Controller/Sensor (USHX) product, launches today on the Android smartphone platform. Southern ... system with DMQ’s remote control and monitoring capability for the first time to ...
(Date:10/13/2015)... , Oct. 13, 2015  Amgen (NASDAQ: ... and Cocoon Biotech, Inc. are Amgen,s 2015 selection for ... space at LabCentral. LabCentral is an innovative, shared laboratory ... startups. Cambridge, Mass. ... ways to deliver potential life-changing therapies. --> ...
(Date:10/13/2015)... SUNNYVALE, Calif. , Oct. 13, 2015  Cepheid ... the quarter ending September 30, 2015. ... financial results, total revenue for the third quarter of ... net loss per share is expected to be approximately ... financial results, non-GAAP net loss per share for the ...
Breaking Biology Technology:
(Date:10/13/2015)... MATEO, Calif. , Oct. 13, 2015 ... real-time, machine-based learning to analyze big data and minimize ... today with Emailage , an innovative fraud prevention ... leverage transactional risk based on a user,s email address. ... a machine learning solution that combines email risk assessment ...
(Date:10/13/2015)... 13, 2015 Dragon Capital Group Corp. ... China , announced today that its wholly ... received a contract for Multi-Format Naked Eye 3D System for ... $450,000 for the project that is expected to be completed ... 35% in gross profits. --> ...
(Date:10/13/2015)... , Oct. 7, 2015 Research and ... the "India Biometrics Authentication & Identification Market - ... --> --> ... $823.46 million in 2014 to $2.06 billion in 2020 ... 2020. India . Growing ...
Breaking Biology News(10 mins):